Akèy › Maladi fwa steatotik › Connecticut › New Haven
Etid klinik pou Maladi fwa steatotik nan New Haven, CT
5 etid pou Maladi fwa steatotik ap chèche patisipan nan sit nan ak bò kote New Haven (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Ap rekriteFaz 3
- Medical Research Center of Connecticut, Hamden · 6 mi lwen
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Ap rekriteFaz 3
- Akero Clinical Study Site, New Haven
Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
Ap rekriteEtid obsèvasyon
- Yale New Haven Hospital, New Haven
Reversal of Lipid-Induced Insulin Resistance
Ap rekriteVolontè an sante akeyi
- Yale Center for Clinical Investigation HRU, New Haven
Digoxin In NASH (CODIN)
Ap rekriteFaz 2
- Yale New Haven Health, New Haven
- Yale New Haven Hospital, New Haven
Etid Maladi fwa steatotik nan lòt vil
- San Antonio, TX17 etid
- New York City, NY16 etid
- Miami, FL16 etid
- San Diego, CA14 etid
- Austin, TX13 etid
- Houston, TX13 etid
- Richmond, VA12 etid
- Tucson, AZ10 etid
- Chandler, AZ10 etid
- St. Louis, MO9 etid
- Hialeah, FL9 etid
- Dallas, TX9 etid
Lòt etid nan New Haven
- Kansè Poumon ki pa ti selil41 etid
- Kansè nan tete38 etid
- Kansè (tout kalite)33 etid
- Kansè Metastatik23 etid
- Kansè poumon22 etid
- Karsinòm selil skuamèz tèt ak kou22 etid
- Kansè ovè21 etid
- Kansè kolorektal20 etid
- Kansè pwostat20 etid
- Leksemi mieloïd egi17 etid
- Twoub Konsomasyon Alkòl (AUD)17 etid
- Sòvdòz Opioyid17 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.